11 March 2002
Further studies of genetic susceptibility to Graves' disease in a Russian population.
Mikhail I Balabolkin, Dimitry A Chistiakov, Valery V Nosikov, Rustam I TurakulovMed Sci Monit 2002; 8(3): CR180-184 :: ID: 420906
Abstract
BACKGROUND: Graves' disease (GD) is a polygenic autoimmune thyroid syndrome.Some of the genes implicated in its pathogenesis may encode thyroid-stimulating hormone receptor (TSHR)and estrogen receptors 1 (ESR1) and 2 (ESR2). We examined dinucleotide repeat polymorphisms in the ESR1and ESR2 genes and D727E amino acid substitution in the TSHR gene for possible association with GD ina Russian population. MATERIAL/METHODS: The polymorphic regions of the target genes were amplified bypolymerase chain reaction (PCR) on the basis of genomic DNA isolated from blood of 78 unrelated Russianpatients with GD and 93 control subjects. To detect the D727E TSHR polymorphism, the PCR product wasadditionally digested with Eco72I restriction endonuclease. The genotype and allele frequencies in thegroups studied were compared by c2 test. The odds ratios and 95% confidence intervals (CI) were calculatedto assess the strength of the relationship between the polymorphisms tested and GD. RESULTS: For polymorphicdinucleotide microsatellites at ESR1 and ESR2, no significant difference was observed in allele frequenciesbetween affected and nonaffected patients. For the D727E TSHR polymorphism, the E allele and the DE genotypewere significantly more frequent (p<0.0001) in patients with GD than in control subjects.
Conclusions: The D727E variant of the TSHR gene is associated with Graves' disease in a Russian population. The E727 allele and the heterozygous D727E genotype are related to higher risk of the disease. No association with GD was found for polymorphic microsatellites of the ESR1 and ESR2.
Keywords: Alleles, Amino Acids, Estrogen Receptor alpha, Estrogen Receptor beta, Genetic Predisposition to Disease, Genotype, Graves, Heterozygote, Microsatellite Repeats, Polymorphism, Genetic, Receptors, Estrogen, Receptors, Thyrotropin, Russia
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952